TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 110 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,000 | -33.3% | 25 | -28.6% | 0.00% | – |
| Q3 2019 | $3,000 | -25.0% | 35 | -28.6% | 0.00% | – |
| Q2 2019 | $4,000 | -33.3% | 49 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | +50.0% | 49 | 0.0% | 0.00% | – |
| Q4 2018 | $4,000 | -71.4% | 49 | -65.5% | 0.00% | – |
| Q3 2018 | $14,000 | -12.5% | 142 | 0.0% | 0.00% | – |
| Q2 2018 | $16,000 | -33.3% | 142 | -42.5% | 0.00% | – |
| Q1 2018 | $24,000 | -36.8% | 247 | -31.2% | 0.00% | -100.0% |
| Q4 2017 | $38,000 | +8.6% | 359 | +13.2% | 0.00% | 0.0% |
| Q3 2017 | $35,000 | -36.4% | 317 | -35.6% | 0.00% | 0.0% |
| Q2 2017 | $55,000 | -12.7% | 492 | -9.4% | 0.00% | 0.0% |
| Q1 2017 | $63,000 | +8.6% | 543 | -2.2% | 0.00% | 0.0% |
| Q4 2016 | $58,000 | -6.5% | 555 | -0.4% | 0.00% | 0.0% |
| Q3 2016 | $62,000 | -21.5% | 557 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $79,000 | – | 557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
| GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
| Think Investments LP | 186,373 | $28,804,000 | 8.16% |
| Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
| Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
| FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
| RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
| Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
| Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |